Doug Biehn Founder of Octave Backed byCasdin CapitalLawrence Canzoneri LinkedIn SourcesOctave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum — 2025-09 Browse all founders · Browse investors